1. Home
  2. Tag "earnings_beat"

EXCLUSIVE: High Tide CEO Highlights Major Drivers Behind Record Earnings, Market Share Growth

While many cannabis retailers in Canada face a tightening market, High Tide Inc. (NASDAQ:HITI) stands out with a robust increase in revenue and market share in its 2024 third-quarter financial results. On Monday, the Calgary-based company reported record revenue of CA$131.7 million ($97 million), marking a 6% increase both year-over-year and sequentially. CEO Raj Grover […]

Here’s Why You Should Add Inogen Stock to Your Portfolio Now

Inogen, Inc. (NASDAQ: INGN) is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid first-quarter 2024 performance and a strong product portfolio, seems justified. However, issues like stiff competition and forex volatility are major downsides. The Zacks Rank #2 (Buy) company’s shares […]

KIDS Stock Gains From Its New Enabling Technologies Division Launch

OrthoPediatrics Corp. (NASDAQ: KIDS) recently launched its Enabling Technologies division, which will leverage the company’s core mission of addressing unmet pediatric needs in orthopedics. The advancement with the latest launch positions OrthoPediatrics at the forefront of the pediatric digital health and enabling technologies sectors. Following the announcement, shares of OrthoPediatrics rose 2.15% to $32.38 on Friday. […]

Here’s Why Investors Should Retain American Airlines Stock Now

American Airlines’ (NASDAQ: AAL) efforts to expand and enhance its global network are commendable. The company’s proactive initiative to create 500 new aviation jobs is serving well for the company and the economy. However, AAL has been grappling with soft market conditions and increased operating costs. Factors Favoring AAL American Airlines’ initiative to create nearly […]

FULC Stock Falls as Muscle Disorder Study Misses Primary Goal

Shares of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) plunged 61.1% on Sept. 12 after the company announced disappointing top-line data from the phase III REACH study, which evaluated its pipeline candidate, losmapimod, for treating patients with facioscapulohumeral muscular dystrophy (FSHD), a rare and debilitating disease. Currently, there are no treatments approved for the given indication. The […]

Affirm’s Survey Reveals 0% APR Option Impact, CEO Outlines Growth Plan

Affirm Holdings, Inc. (NASDAQ: AFRM) recently unveiled results from its latest survey, highlighting consumer shopping behaviors before the holiday season of 2024. The study of 2,000 Americans unveiled how the 0% annual percentage rate (APR) options would influence consumers while making purchase decisions and how confident they are about budgeting. This bodes well for a company […]

RH Shares Leap On Heels Of Q2 Revenue Report, But Analysts Say Management Is ‘Too Optimistic’

Shares of RH (NYSE:RH) climbed 23.6% at last check Friday, after the company reported upbeat second-quarter results. The company, also known as Restoration Hardware, reported its results amid an exciting earnings season. Here are some key analyst takeaways. Bank of America analyst Curtis Nagle reiterated a Buy rating, while lifting the price target from $310 […]

Can QGEN Stock Gain From the Expanded Bio-Manguinhos/Fiocruz Alliance?

QIAGEN N.V. (NYSE: QGEN) announced the expansion of its strategic partnership with Bio-Manguinhos/Fiocruz, a leading vaccines and diagnostics supplier to the Brazilian Ministry of Health. Initiated in 2009, the expanded collaboration allows Bio-Manguinhos to launch an advanced PCR (Polymerase Chain Reaction)-based molecular screening platform to detect malaria alongside HIV, hepatitis B and C virus, a capability […]